Sexual Behavior in Head and Neck Cancer Patients
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/24/2018 |
| Start Date: | April 2008 |
| End Date: | April 2020 |
The goal of this behavioral research study is to learn if certain sexual behaviors increase
the risk for developing head and neck cancers associated with a virus called human
papillomavirus (HPV-16). Knowing this information could help doctors better teach patients
about avoiding certain risk factors, which may help to prevent the disease.
the risk for developing head and neck cancers associated with a virus called human
papillomavirus (HPV-16). Knowing this information could help doctors better teach patients
about avoiding certain risk factors, which may help to prevent the disease.
SCCHN is believed to be caused by different types of viruses being exposed to the mucous
membrane on the inside of the mouth, throat, and voice box, over a long period of time. This
exposure results in changes in the cells of the mouth, throat, and voice box, which can lead
to the development of cancer.
HPV-16 has been linked to SCCHN. Half of all cancers of the oropharynx (the middle part of
the throat, the base of the tongue, and tonsils) may be caused by HPV-16. HPV-16 is normally
spread sexually, and is one of the main causes of cervical cancer in women. By finding out if
the virus is also spread sexually to the throat, doctors may be able to teach patients about
risk factors for developing cancer in this area.
Study Procedures:
If you agree to take part in this study, you will be asked to complete a questionnaire about
your sexual history, such as specific sexual practices, number of partners, exposure to HPV
and other viruses, and any medical history related to HPV-16. The questionnaire will take
10-15 minutes to complete.
None of your personal identifying information will be attached to your questionnaire, and the
questionnaire will be assigned a one-of-a-kind study code number.
To check your cancer diagnosis, your medical records will be reviewed.
Length of Study:
Once you have completed the questionnaire, your participation in this study is over.
This is an investigational study.
Up to 1,500 patients will be enrolled in this study. All will be enrolled at MD Anderson.
membrane on the inside of the mouth, throat, and voice box, over a long period of time. This
exposure results in changes in the cells of the mouth, throat, and voice box, which can lead
to the development of cancer.
HPV-16 has been linked to SCCHN. Half of all cancers of the oropharynx (the middle part of
the throat, the base of the tongue, and tonsils) may be caused by HPV-16. HPV-16 is normally
spread sexually, and is one of the main causes of cervical cancer in women. By finding out if
the virus is also spread sexually to the throat, doctors may be able to teach patients about
risk factors for developing cancer in this area.
Study Procedures:
If you agree to take part in this study, you will be asked to complete a questionnaire about
your sexual history, such as specific sexual practices, number of partners, exposure to HPV
and other viruses, and any medical history related to HPV-16. The questionnaire will take
10-15 minutes to complete.
None of your personal identifying information will be attached to your questionnaire, and the
questionnaire will be assigned a one-of-a-kind study code number.
To check your cancer diagnosis, your medical records will be reviewed.
Length of Study:
Once you have completed the questionnaire, your participation in this study is over.
This is an investigational study.
Up to 1,500 patients will be enrolled in this study. All will be enrolled at MD Anderson.
Inclusion Criteria:
1. Patients with newly diagnosed, previously untreated squamous cell carcinoma of the
head and neck (SCCHN) who are candidates for the molecular epidemiology study
LAB00-062 of head and neck cancer.
2. Must have the ability to understand and provide informed consent.
3. Patients must be 18 years and older.
4. Ability to read, write, and speak English.
5. Resident of the United States.
6. Agrees to have tumor tissue, if available, tested for HPV. No additional biopsy will
be requested.
Exclusion Criteria:
1. Previous cancer diagnosis excluding non-melanoma skin cancer.
2. Blood transfusion within the previous 6 months.
3. Immune suppression, such as HIV disease or immune-suppressing therapy (i.e.,
steroids).
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
